Guardant Health, Inc. is 6.8x more valuable than GRAIL, LLC by market capitalization ($17.45 B vs $2.57 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GRAL | GH |
|---|---|---|
| Market cap | $2.57 B | $17.45 B |
| US-listed rank | #1944 | #680 |
| Revenue (latest FY) | $147.17M | $982.02M |
| Net income (latest FY) | -$408.35M | -$416.30M |
| Net margin | -277.5% | -42.4% |
| SEC filings | 228 | 1,131 |
Guardant Health, Inc. is 6.8x more valuable than GRAIL, LLC by market capitalization ($17.45 B vs $2.57 B).
In their latest fiscal years, GRAIL, LLC reported $147.17M in revenue while Guardant Health, Inc. reported $982.02M.
Full pages: GRAIL, LLC and Guardant Health, Inc., or browse the full rankings.